Screening in Myocardial Perfusion Patients
| Status: | Archived |
|---|---|
| Conditions: | Breast Cancer, Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 7/1/2011 |
| Start Date: | July 2008 |
| End Date: | July 2012 |
Screening for Breast Cancer in Patients Undergoing Myocardial Perfusion Imaging
To expand the understanding of the uptake and distribution of Tc-99m sestamibi in the breast
in a normal female population undergoing myocardial perfusion imaging using Molecular Breast
Imaging (MBI).
You are being asked to take part in this research study because you have been scheduled to
have a scan of your heart. The radioactive dye used to image your heart is also taken up by
many types of breast cancer. The investigators have developed a new method for detecting
breast cancer, called Molecular Breast Imaging that uses this dye.
The purpose of this study is to see how well this new method works in normal subjects with
no known breast cancer and to see if we can detect breast cancer at an earlier stage than
mammography. As you read this form describing the study, ask any questions you have. Take
your time to decide. Feel free to discuss the study with your family, friends, and
healthcare provider before you decide. You may stop participating at any time during the
study. You may decide not to participate. If so, none of your current benefits or normal
health care will be affected in any way. When you feel comfortable that all your questions
have been answered, and you wish to take part in this study, sign this form in order to
begin your participation. Your signature means you have been told about the study and what
the risks are. Your signature on this form also means that you want to take part in this
study.
We found this trial at
1
site
Mayo Clinic Rochester Mayo Clinic is a nonprofit worldwide leader in medical care, research and...
Click here to add this to my saved trials
